121 related articles for article (PubMed ID: 34395761)
1. HCV Reporter System (Viral Infection-Activated Split-Intein-Mediated Reporter System) for Testing Virus Cell-to-cell Transmission
Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
Bio Protoc; 2018 Aug; 8(15):e2949. PubMed ID: 34395761
[TBL] [Abstract][Full Text] [Related]
2. Visualizing the Essential Role of Complete Virion Assembly Machinery in Efficient Hepatitis C Virus Cell-to-Cell Transmission by a Viral Infection-Activated Split-Intein-Mediated Reporter System.
Zhao F; Zhao T; Deng L; Lv D; Zhang X; Pan X; Xu J; Long G
J Virol; 2017 Jan; 91(2):. PubMed ID: 27852847
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.
Velázquez-Moctezuma R; Galli A; Law M; Bukh J; Prentoe J
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487284
[TBL] [Abstract][Full Text] [Related]
4. Cell-to-Cell Transmission Is the Main Mechanism Supporting Bovine Viral Diarrhea Virus Spread in Cell Culture.
Merwaiss F; Czibener C; Alvarez DE
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404802
[TBL] [Abstract][Full Text] [Related]
5. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells.
Witteveldt J; Evans MJ; Bitzegeio J; Koutsoudakis G; Owsianka AM; Angus AG; Keck ZY; Foung SK; Pietschmann T; Rice CM; Patel AH
J Gen Virol; 2009 Jan; 90(Pt 1):48-58. PubMed ID: 19088272
[TBL] [Abstract][Full Text] [Related]
6. Attachment and Postattachment Receptors Important for Hepatitis C Virus Infection and Cell-to-Cell Transmission.
Fan H; Qiao L; Kang KD; Fan J; Wei W; Luo G
J Virol; 2017 Jul; 91(13):. PubMed ID: 28404852
[TBL] [Abstract][Full Text] [Related]
7. Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission.
Catanese MT; Loureiro J; Jones CT; Dorner M; von Hahn T; Rice CM
J Virol; 2013 Aug; 87(15):8282-93. PubMed ID: 23698298
[TBL] [Abstract][Full Text] [Related]
8. Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial.
Cypel M; Feld JJ; Galasso M; Pinto Ribeiro RV; Marks N; Kuczynski M; Kumar D; Bahinskaya I; Bagnato VS; Kurachi C; Slutsky AS; Yeung JC; Donahoe L; de Perrot M; Yasufuku K; Pierre A; Binnie M; Chaparro C; Martinu T; Chen M; Tikkanen J; Chow CW; Sidhu A; Waddell TK; Keshavjee S; Singer LG; Humar A
Lancet Respir Med; 2020 Feb; 8(2):192-201. PubMed ID: 31606437
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
Xiao F; Fofana I; Heydmann L; Barth H; Soulier E; Habersetzer F; Doffoël M; Bukh J; Patel AH; Zeisel MB; Baumert TF
PLoS Pathog; 2014 May; 10(5):e1004128. PubMed ID: 24830295
[TBL] [Abstract][Full Text] [Related]
10. Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
Haberstroh A; Schnober EK; Zeisel MB; Carolla P; Barth H; Blum HE; Cosset FL; Koutsoudakis G; Bartenschlager R; Union A; Depla E; Owsianka A; Patel AH; Schuster C; Stoll-Keller F; Doffoël M; Dreux M; Baumert TF
Gastroenterology; 2008 Nov; 135(5):1719-1728.e1. PubMed ID: 18718838
[TBL] [Abstract][Full Text] [Related]
11. Adaptive Mutations Enhance Assembly and Cell-to-Cell Transmission of a High-Titer Hepatitis C Virus Genotype 5a Core-NS2 JFH1-Based Recombinant.
Mathiesen CK; Prentoe J; Meredith LW; Jensen TB; Krarup H; McKeating JA; Gottwein JM; Bukh J
J Virol; 2015 Aug; 89(15):7758-75. PubMed ID: 25995244
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission.
Brimacombe CL; Grove J; Meredith LW; Hu K; Syder AJ; Flores MV; Timpe JM; Krieger SE; Baumert TF; Tellinghuisen TL; Wong-Staal F; Balfe P; McKeating JA
J Virol; 2011 Jan; 85(1):596-605. PubMed ID: 20962076
[TBL] [Abstract][Full Text] [Related]
13. Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release.
Xiao F; Wang S; Barouch-Bentov R; Neveu G; Pu S; Beer M; Schor S; Kumar S; Nicolaescu V; Lindenbach BD; Randall G; Einav S
mBio; 2018 Mar; 9(2):. PubMed ID: 29535204
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus Cell-to-cell Spread Assay.
Barretto N; Uprichard SL
Bio Protoc; 2014 Dec; 4(24):. PubMed ID: 29104884
[TBL] [Abstract][Full Text] [Related]
15. Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact.
Valli MB; Serafino A; Crema A; Bertolini L; Manzin A; Lanzilli G; Bosman C; Iacovacci S; Giunta S; Ponzetto A; Clementi M; Carloni G
J Med Virol; 2006 Feb; 78(2):192-201. PubMed ID: 16372297
[TBL] [Abstract][Full Text] [Related]
16. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies.
Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S
Virol J; 2007 Mar; 4():35. PubMed ID: 17397531
[TBL] [Abstract][Full Text] [Related]
17. A novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmission.
Fofana I; Xiao F; Thumann C; Turek M; Zona L; Tawar RG; Grunert F; Thompson J; Zeisel MB; Baumert TF
PLoS One; 2013; 8(5):e64221. PubMed ID: 23704981
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses.
Koutsoudakis G; Kaul A; Steinmann E; Kallis S; Lohmann V; Pietschmann T; Bartenschlager R
J Virol; 2006 Jun; 80(11):5308-20. PubMed ID: 16699011
[TBL] [Abstract][Full Text] [Related]
19. A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.
Liu S; Xiao L; Nelson C; Hagedorn CH
PLoS One; 2012; 7(9):e44965. PubMed ID: 23028707
[TBL] [Abstract][Full Text] [Related]
20. Mutations that alter use of hepatitis C virus cell entry factors mediate escape from neutralizing antibodies.
Fofana I; Fafi-Kremer S; Carolla P; Fauvelle C; Zahid MN; Turek M; Heydmann L; Cury K; Hayer J; Combet C; Cosset FL; Pietschmann T; Hiet MS; Bartenschlager R; Habersetzer F; Doffoël M; Keck ZY; Foung SKH; Zeisel MB; Stoll-Keller F; Baumert TF
Gastroenterology; 2012 Jul; 143(1):223-233.e9. PubMed ID: 22503792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
